Peter Boer

Peter Boer

Auto-generated profile, based on publicly available information

Peter Boer

Department of Nephrology, University Medical Center, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2004 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
JVJ. L. Tycho Vuurmans
J. L. Tycho Vuurmans
PBPeter Boer
Peter Boer
HKHein A. Koomans
Hein A. Koomans
Background. In patients with renal or cardiac failure, renal function may be endangered by elevated plasma concentrations of the vasoconstrictor endothelin-1 (ET-1). To mimic effects of pathologically increased plasma ET-1, we gave intravenous ET-1 in healthy subjects and examined whether simultaneous infusion of the ETA-receptor antagonist VML 588 would prevent the effects of ET-1 on the kidney. Methods. Nine healthy men received on four separate days intravenous infusion of ET-1 (2.5 ng/kg/min) superimposed on vehicle (saline) or on VML 588 infusion (0.05, 0.20 and 0.40 mg/kg/h) in randomized order to assess the effects on renal function and renal haemodynamics. Results. At resting plasma ET-1, infusion of VML 588 alone had no significant effects on renal function. Infusion of ET-1 alone decreased glomerular filtration rate by 11% and this reduction was not reversed by co-infusion of VML 588. ET-1 reduced renal blood flow by 35% and VML 588 reduced this decrease by one-third, in a dose-independent fashion. ET-1 increased the filtration fraction by 34% and VML 588 reduced this increase dose-independently by one-half. ET-1 increased renal vascular resistance by 59% and VML 588 reduced this increase dose-independently by one-half. Finally, ET-1 decreased sodium excretion by 58% and VML 588 reduced this decrease dose-independently by two-thirds. Conclusions. ET-1-induced reductions in renal function were partially but not completely prevented in a dose-independent manner by the ETA-receptor antagonist VML 588.

1 January 1993 in Journal of Analytical Atomic Spectrometry
Verified
Journal Article
Closed access
PDF file
PBPeter Boer
Peter Boer
WBWalther H. Boer
Walther H. Boer
HKHein A. Koomans
Hein A. Koomans
RFRené Fransen
René Fransen
A method for the determination of lithium by electrothermal atomic absorption spectrometry in nanolitre samples of tubular fluid of rat kidneys was developed. The signal-to-noise ratio was improved by use of tantalum foil in the atomization step. Peak height absorbance increased ten times and integrated absorbance four times. The atomization temperature could be reduced by 300 °C. The sensitivity increased from 1.7 to 0.45 pmol, which permits the determination of lithium in 10 nl samples. Addition of lithium-free tubular fluid to lithium standards showed that no matrix effects were present and that background correction was not required. At a level of 0.25 mmol l–1, the within-day and between-day relative standard deviations (RSDs) were 5 and 4%, respectively. For plasma, the within-day and between-day RSDs were also 5 and 4%, respectively, at a level of 0.25 mmol l–1. The recovery of lithium standards added to plasma was 99 ± 4%. In untreated anaesthetized rats, the tubular fluid-to-plasma lithium concentration ratio for the late proximal part of the renal tubule was 1.10 ± 0.10 (mean ± SD; n= 180) and for the early distal part of the tubule 1.08 ± 0.13 (n= 102). Since tubular fluid-to-plasma concentration ratios can be assessed in both proximal and distal tubular fluid, the proposed method provides a tool to test whether lithium is a good marker of proximal tubular sodium reabsorption.

1 May 2007 in Hypertension
Verified
Journal Article
Closed access
PDF file
JNJutta Neumann
Jutta Neumann
GLGerry Ligtenberg
Gerry Ligtenberg
IKInge H.T. Klein
Inge H.T. Klein
PBPeter Boer
Peter Boer
POP. Liam Oey
P. Liam Oey
PBPeter J Blankestijn
Peter J Blankestijn

1 August 2003 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
PDF file
TVTycho Vuurmans
Tycho Vuurmans
HKHein Koomans
Hein Koomans
PBPeter Boer
Peter Boer